Connect Biopharma Holdings Limited (CNTB): Is this the Most Sought-After Stock Today? – Invest Chronicle
Home  »  Industry   »  Connect Biopharma Holdings Limited (CNTB): Is this...

Connect Biopharma Holdings Limited (CNTB): Is this the Most Sought-After Stock Today?

For the readers interested in the stock health of Connect Biopharma Holdings Limited (CNTB). It is currently valued at $0.62. When the transactions were called off in the previous session, Stock hit the highs of $0.656, after setting-off with the price of $0.6141. Company’s stock value dipped to $0.5605 during the trading on the day. When the trading was stopped its value was $0.58.Recently in News on May 3, 2022, Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis. Primary endpoint of change from baseline on adapted Mayo Score for CBP-307 0.2 mg once-daily, orally administered dose showed a numerical improvement, but did not achieve statistical significance . You can read further details here

Connect Biopharma Holdings Limited had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.9900 on 01/04/22, with the lowest value was $0.5573 for the same time period, recorded on 05/09/22.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Connect Biopharma Holdings Limited (CNTB) full year performance was -95.94%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Connect Biopharma Holdings Limited shares are logging -97.87% during the 52-week period from high price, and 12.13% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.56 and $29.27.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 681827 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Connect Biopharma Holdings Limited (CNTB) recorded performance in the market was -87.87%, having the revenues showcasing -86.17% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 35.92M, as it employees total of 62 workers.

Analysts verdict on Connect Biopharma Holdings Limited (CNTB)

During the last month, 0 analysts gave the Connect Biopharma Holdings Limited a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 3.7138, with a change in the price was noted -4.10. In a similar fashion, Connect Biopharma Holdings Limited posted a movement of -86.76% for the period of last 100 days, recording 268,448 in trading volumes.

Connect Biopharma Holdings Limited (CNTB): Technical Analysis

Raw Stochastic average of Connect Biopharma Holdings Limited in the period of last 50 days is set at 1.54%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.73%. In the last 20 days, the company’s Stochastic %K was 1.34% and its Stochastic %D was recorded 0.79%.

Let’s take a glance in the erstwhile performances of Connect Biopharma Holdings Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -87.87%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -95.63%, alongside a downfall of -95.94% for the period of the last 12 months. The shares increased approximately by -23.81% in the 7-day charts and went up by -78.45% in the period of the last 30 days. Common stock shares were lifted by -86.17% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts